Synopsis
Synopsis
0
JDMF
0
EU WC
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
Annual Reports
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Lariam
2. Mefloquine
3. Mefloquine Hydrochloride
4. Mephloquine
5. Ro 21 5998 001
6. Ro-21-5998-001
7. Ro215998001
8. Wr 142,490
9. Wr 177,602
10. Wr-142,490
11. Wr-177,602
12. Wr142,490
13. Wr177,602
1. Mefloquine Hydrochloride
2. Mefloquine Hcl
3. 51773-92-3
4. Mefloquine (hydrochloride)
5. Loriam
6. Mefloquine Hydrochloride, (+)
7. 51742-86-0
8. 326vc85gv6
9. Ro 21-5998/001
10. Mefloquinehydrochloride
11. 5y9l3636o3
12. Ro-21-5998/001
13. (s)-[2,8-bis(trifluoromethyl)quinolin-4-yl]-[(2r)-piperidin-2-yl]methanol;hydrochloride
14. Dsstox_cid_27796
15. Dsstox_rid_82568
16. Dsstox_gsid_47819
17. Mls001332559
18. Nsc-157387
19. (r)-[2,8-bis(trifluoromethyl)quinolin-4-yl](2s)-piperidin-2-ylmethanol Hydrochloride
20. (s)-[2,8-bis(trifluoromethyl)quinolin-4-yl][(2r)-piperidin-2-yl]methanol Hydrochloride
21. Wr 142490 Hydrochloride
22. Nsc 157387
23. Cas-51773-92-3
24. Mefloquine Hydrochloride [usan]
25. Mefloquin Hydrochloride
26. Ncgc00161831-02
27. Smr000875233
28. Einecs 257-412-0
29. Wr-142490
30. Tcmdc-124288
31. Unii-326vc85gv6
32. Unii-5y9l3636o3
33. Gnf-pf-5559
34. Lariam (tn)
35. Mefloquine Hydrochloride [usan:usp]
36. Ro-215998001
37. Chembl1606
38. Dl-erythro-alpha-2-piperidyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol Monohydrochloride
39. Schembl41094
40. Mls001332560
41. Chebi:6719
42. (+/-)-mefloquine Hcl
43. Dtxsid1047819
44. Tox21_111999
45. Hy-17437a
46. Mfcd00797519
47. S4420
48. Mefloquine Hydrochloride (jp17/usp)
49. Mefloquine Hydrochloride [jan]
50. Akos015919767
51. Tox21_111999_1
52. Ac-4686
53. Ccg-268825
54. Cs-1430
55. Gs-3621
56. Nc00622
57. (r*,s*)-(1)-alpha-2-piperidyl-2,8-bis(trifluoromethyl)quinoline-4-methanol Monohydrochloride
58. Mefloquine Hydrochloride [mart.]
59. Mefloquine Hydrochloride [vandf]
60. Mefloquine Hydrochloride [usp-rs]
61. Mefloquine Hydrochloride [who-dd]
62. Mefloquine Hydrochloride [who-ip]
63. Ncgc00161831-04
64. 4-quinolinemethanol, Alpha-(2r)-2-piperidinyl-2,8-bis(trifluoromethyl)-, Monohydrochloride, (alphas)-rel-
65. 4-quinolinemethanol, Alpha-2-piperidinyl-2,8-bis(trifluoromethyl)-, Monohydrochloride, (r*,s*)-(+-)-
66. M2313
67. Sw220098-1
68. Mefloquine Hydrochloride [ep Impurity]
69. Mefloquine Hydrochloride [orange Book]
70. D00831
71. Mefloquine Hydrochloride [ep Monograph]
72. Mefloquine Hydrochloride [usp Monograph]
73. Mefloquini Hydrochloridum [who-ip Latin]
74. Mefloquine Hydrochloride, >=98% (hplc), Powder
75. Q-201345
76. Mefloquine Hydrochloride, European Pharmacopoeia (ep) Reference Standard
77. (?s)-rel-?-(2r)-2-piperidinyl-2,3-bis(trifluoromethyl-4-quinolinemethanol Hydrochloride
78. (2,8-bis-trifluoromethylquinolin-4-yl)-piperidin-2-yl-methanol Hydrochloride(r*,s*)
79. Mefloquine Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
80. Mefloquine Hydrochloride, United States Pharmacopeia (usp) Reference Standard
81. Rel-(s)-(2,8-bis(trifluoromethyl)quinolin-4-yl)((r)-piperidin-2-yl)methanol Hydrochloride
82. (as)?-?rel-?a-?(2r)?-?2-?piperidinyl-?2,8-?bis(trifluoromethyl)?-?4-?quinolinemethanol Monohydrochloride
83. 4-quinolinemethanol, .alpha,-[(2r)-2-piperidinyl]-2,8-bis(trifluoromethyl)-, (.alpha.s)-, Hydrochloride (1:1)
84. 4-quinolinemethanol, .alpha.-(2r)-2-piperidinyl-2,8-bis(trifluoromethyl)-, Hydrochloride (1:1), (.alpha.s)-
85. 4-quinolinemethanol, .alpha.-(2r)-2-piperidinyl-2,8-bis(trifluoromethyl)-, Monohydrochloride, (.alpha.s)-
86. 4-quinolinemethanol, .alpha.-2-piperidinyl-2,8-bis(trifluoromethyl)-, Monohydrochloride, (r*,s*)- (+/-)-
87. 4-quinolinemethanol, A-(2r)-2-piperidinyl-2,8-bis(trifluoromethyl)-,monohydrochloride, (as)-rel-
88. Dl-erythro-.alpha.-2-piperidyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol Monohydrochloride
Molecular Weight | 414.8 g/mol |
---|---|
Molecular Formula | C17H17ClF6N2O |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 9 |
Rotatable Bond Count | 2 |
Exact Mass | 414.0933598 g/mol |
Monoisotopic Mass | 414.0933598 g/mol |
Topological Polar Surface Area | 45.2 Ų |
Heavy Atom Count | 27 |
Formal Charge | 0 |
Complexity | 483 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Mefloquine hydrochloride |
Drug Label | Mefloquine hydrochloride is an antimalarial agent available as 250 mg tablets of mefloquine hydrochloride (equivalent to 228.0 mg of the free base) for oral administration.Mefloquine hydrochloride is a 4-quinolinemethanol derivative with the specific... |
Active Ingredient | Mefloquine hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 250mg |
Market Status | Prescription |
Company | Sandoz; Roxane; Barr |
2 of 2 | |
---|---|
Drug Name | Mefloquine hydrochloride |
Drug Label | Mefloquine hydrochloride is an antimalarial agent available as 250 mg tablets of mefloquine hydrochloride (equivalent to 228.0 mg of the free base) for oral administration.Mefloquine hydrochloride is a 4-quinolinemethanol derivative with the specific... |
Active Ingredient | Mefloquine hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 250mg |
Market Status | Prescription |
Company | Sandoz; Roxane; Barr |
Antimalarials
Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) (See all compounds classified as Antimalarials.)
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
77
PharmaCompass offers a list of Mefloquine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Mefloquine manufacturer or Mefloquine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Mefloquine manufacturer or Mefloquine supplier.
PharmaCompass also assists you with knowing the Mefloquine API Price utilized in the formulation of products. Mefloquine API Price is not always fixed or binding as the Mefloquine Price is obtained through a variety of data sources. The Mefloquine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A CS-1430 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of CS-1430, including repackagers and relabelers. The FDA regulates CS-1430 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. CS-1430 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of CS-1430 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A CS-1430 supplier is an individual or a company that provides CS-1430 active pharmaceutical ingredient (API) or CS-1430 finished formulations upon request. The CS-1430 suppliers may include CS-1430 API manufacturers, exporters, distributors and traders.
click here to find a list of CS-1430 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A CS-1430 DMF (Drug Master File) is a document detailing the whole manufacturing process of CS-1430 active pharmaceutical ingredient (API) in detail. Different forms of CS-1430 DMFs exist exist since differing nations have different regulations, such as CS-1430 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A CS-1430 DMF submitted to regulatory agencies in the US is known as a USDMF. CS-1430 USDMF includes data on CS-1430's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The CS-1430 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of CS-1430 suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a CS-1430 Drug Master File in Korea (CS-1430 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of CS-1430. The MFDS reviews the CS-1430 KDMF as part of the drug registration process and uses the information provided in the CS-1430 KDMF to evaluate the safety and efficacy of the drug.
After submitting a CS-1430 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their CS-1430 API can apply through the Korea Drug Master File (KDMF).
click here to find a list of CS-1430 suppliers with KDMF on PharmaCompass.
A CS-1430 CEP of the European Pharmacopoeia monograph is often referred to as a CS-1430 Certificate of Suitability (COS). The purpose of a CS-1430 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of CS-1430 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of CS-1430 to their clients by showing that a CS-1430 CEP has been issued for it. The manufacturer submits a CS-1430 CEP (COS) as part of the market authorization procedure, and it takes on the role of a CS-1430 CEP holder for the record. Additionally, the data presented in the CS-1430 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the CS-1430 DMF.
A CS-1430 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. CS-1430 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of CS-1430 suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing CS-1430 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for CS-1430 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture CS-1430 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain CS-1430 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a CS-1430 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of CS-1430 suppliers with NDC on PharmaCompass.
CS-1430 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of CS-1430 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right CS-1430 GMP manufacturer or CS-1430 GMP API supplier for your needs.
A CS-1430 CoA (Certificate of Analysis) is a formal document that attests to CS-1430's compliance with CS-1430 specifications and serves as a tool for batch-level quality control.
CS-1430 CoA mostly includes findings from lab analyses of a specific batch. For each CS-1430 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
CS-1430 may be tested according to a variety of international standards, such as European Pharmacopoeia (CS-1430 EP), CS-1430 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (CS-1430 USP).